SGLT2i	Sodium glucose co-transporter 2 inhibitors
HF	Heart failure
AF	Atrial fibrillation
RCTs	Randomized controlled trials
NIH	National Institutes of Health
ROB	Risk of bias
OR	Odds ratio
CI	Confidence interval
LAD	Left atrial diameter
CA	Catheter ablation
eGFR	Estimated glomerular filtration rate
LVEF	Left ventricular ejection fraction
HTN	Hypertension
T2DM	Type 2 diabetes mellitus
COPD	Chronic obstructive pulmonary disease
CVA	Cerebrovascular accident
CAD	Coronary artery disease
HLD	Hyperlipidemia
AAD	Anti-arrhythmic drugs
GLP1	Glucagon-like peptide-1
DPP4i	Dipeptidyl peptidase-4 inhibitors
PVI	Pulmonary vein isolation
CTI	Cavo-tricuspid isthmus
SVCI	Superior vena cava isolation
RFCA	Radiofrequency catheter ablation
TGF	Transforming growth factor
NHE	Sodium-hydrogen exchanger
NCX	Sodium-calcium exchanger
SERCA	Sarco/Endoplasmic Reticulum Calcium ATPase
AMPK	Adenosine monophosphate-activated protein kinase
SIRT1	Sirtuin-1
PGC-1α	Peroxisome proliferator-activated receptor-gamma coactivator 1α
IL	Interleukin
TNF	Tumor necrosis factor
CHA2DS2 VASc	Congestive heart failure, Hypertension, Age (≥75, doubled), Diabetes, Stroke/TIA (doubled), Vascular disease, Age (65–74), Sex category (Female)